Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Abroad (travel likely)RecruitingPHASE3

Conditions

Anemia · Chronic Kidney Disease · Chronic Kidney Disease Patients on Hemodialysis · Chronic Kidney Disease 5D

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus
Contact: Study coordinator (Komissarov K.S.) · mnpc.htg@mail.ru · +375 (17) 277 10 91
B. Braun Avitum Russland Clinics Ltd., Saint Petersburg, Russia
Contact: Study coordinator (Sabodash A.B.) · spb1.ru@bbraun.com · +7 (812) 640 13 04

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Anemia · Iron Deficiencies · Chronic Kidney Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Melbourne, Australia

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Iron Deficiency Anemia

Abroad (travel likely)RecruitingPHASE3

Little Rock, United States · Gainesville, United States

Biocollection in MyeloDysplastic Syndrome (P-MDS)

Myelodysplastic Syndromes · Myelodysplastic Anemia · Myelodysplastic Syndrome With Isolated Del(5Q)

Abroad (travel likely)Recruiting

Brest, France

Luspatercept for CIA in AML

Chemotherapy-inducing Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China